Statements (55)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:High_School
|
| gptkbp:bfsLayer |
3
|
| gptkbp:bfsParent |
gptkb:Stripe
gptkb:India |
| gptkbp:applies_to |
cardiovascular health
|
| gptkbp:based_on |
prothrombin time (PT)
|
| gptkbp:can_be |
risk of bleeding
|
| gptkbp:designated_as |
a ratio
|
| gptkbp:developed_by |
gptkb:World_Health_Organization
|
| gptkbp:ensures |
therapeutic effectiveness
|
| gptkbp:game_components |
thromboprophylaxis
|
| gptkbp:has_part |
patients on warfarin
|
| https://www.w3.org/2000/01/rdf-schema#label |
INR
|
| gptkbp:is_affected_by |
vitamin K intake
|
| gptkbp:is_analyzed_in |
bleeding disorders
antithrombotic therapy anticoagulation levels the INR formula therapeutic ranges |
| gptkbp:is_associated_with |
various medications
|
| gptkbp:is_critical_for |
patient outcomes
emergency medicine |
| gptkbp:is_essential_for |
patient safety
surgical procedures preventing blood clots patients with atrial fibrillation long-term anticoagulation management |
| gptkbp:is_influenced_by |
liver function
|
| gptkbp:is_monitored_by |
thromboembolic events
point-of-care testing devices patients with mechanical heart valves |
| gptkbp:is_part_of |
coagulation profile
|
| gptkbp:is_related_to |
thrombosis
|
| gptkbp:is_represented_in |
a numerical value
|
| gptkbp:is_standardized_by |
anticoagulation therapy
anticoagulant therapy monitoring patient management in anticoagulation therapy |
| gptkbp:is_used_for |
monitoring anticoagulant therapy
|
| gptkbp:is_used_in |
clinical trials
clinical settings |
| gptkbp:key |
coagulation status
|
| gptkbp:measures |
laboratories
preventive medicine vitamin K antagonism blood coagulation blood thinning effectiveness clotting time warfarin therapy |
| gptkbp:provides_information_on |
clinical decision making
treatment protocols dosage adjustments |
| gptkbp:range |
0.8 to 1.1
|
| gptkbp:was_a_factor_in |
clinical assessments
patient management stroke prevention |